2
Announcements
Trials
Browse
Landscape
Phase
Phase NA
1
Status
Unknown
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Breast Neoplasms
7
Vulvar Neoplasms
2
Vaginal Neoplasms
2
Uterine Cervical Neoplasms
2
Polycystic Ovary Syndrome
2
Vaginal Atrophy
1
Triple Negative Breast Neoplasms
1
Sexual Dysfunction, Physiological
1
Sarcoma, Synovial
1
Rectal Neoplasms
1
Neoplasms, Plasma Cell
1
Multiple Myeloma
1
Metastatic Breastcancer
1
Insulin Resistance
1
Fallopian Tube Neoplasms
1
Endometrial Neoplasms
1
Endocrine System Diseases
1
Depression
1
Carcinoma, Ovarian Epithelial
1
Breast Neoplasms, Male
1
Atrophic Vaginitis
1
Anxiety Disorders
1
Anus Neoplasms
1
Interventions
Metformin
30
Exercise
8
Pioglitazone
7
Inositol
6
Insulin
5
Acupuncture Therapy
4
High-Intensity Interval Training
3
Ethinyl Estradiol
3
salicylsalicylic acid
2
drospirenone and ethinyl estradiol combination
2
Water
2
Tablets
2
Surveys and Questionnaires
2
Sugars
2
Resistance Training
2
Preoperative Exercise
2
Observation
2
Folic Acid
2
Diet Therapy
2
Cyproterone Acetate
2
Cholecalciferol
2
Caloric Restriction
2
Biguanides
2
ziprasidone
1
maltodextrin
1
lime
1
licogliflozin
1
exendin (9-39)
1
drospirenone
1
cinnulin PF
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Insulin Resistance
×
Dehydroepiandrosterone
×
Clear all
NCT05263557
2023-07-25
DIMOXIS
Royal College of Surgeons, Ireland
Phase NA
Unknown
20 enrolled